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Background: Elevated pulmonary arterial pressure may increase right ventricular (RV) oxidative metabolism in patients with pulmonary 
hypertension (PH). A pulmonary hypertension (PH)-specific vasodilator decreases pulmonary arterial pressure. However, it is not clear whether such a 
treatment favorably affects RV myocardial oxidative metabolism. The purpose of this study was to investigate the possible impacts of the intensified 
PH-specific vasodilator therapy on myocardial energetics using 11C acetate PET.
methods: Nine PH patients who had additional or increased doses of PH-specific vasodilator (s) based on ESC/ERS guidelines for diagnosis and 
management of PH were compared with 5 PH patients who had no treatment modification (control group). Pulmonary vascular resistance (PVR) 
was calculated based on right heart catheterization data. Ventricular function was assessed using magnetic resonance imaging (MRI). Dynamic 
11C-acetate PET was used to simultaneously measure RV and left ventricular (LV) oxidative metabolism (kmono). RV myocardial work per oxygen 
consumption index was calculated as follows [RV stroke volume index (SVI) / RV kmono]. Measurements were performed at baseline and after 10±6 
months follow-up.
results: Intensified PH therapy group tended to reduce PVR compared with control group (-20.6±41.7 vs. -3.4±33.2%, P=0.29). Intensified PH 
therapy significantly reduced RV oxidative metabolism (0.044±0.008 to 0.039±0.007/min, P=0.002) while increasing SVI (31.4±10.1 to 39.3±9.6 
mL/m2, P=0.017). As a result, the intensified therapy significantly improved the RV work/oxygen consumption index (730.8±253.6 to 1038.5±262.7 
mL/min•m2, P<0.001). There was no significant change in LV kmono in this group (P=0.35. The control group did not change in these parameters (RV 
kmono: P=0.15, RV work/oxygen consumption index: P=0.69).
conclusions: Intensified PH-specific vasodilator therapy led to a reduction in right ventricular oxidative metabolism and a significant improvement 
in right ventricular work per oxygen consumption index in patients with pulmonary hypertension. These effects may contribute to the benefits of the 
intensified PH-specific vasodilator therapy.
